Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
misetionamide (GP-2250)
i
Other names:
GP-2250, substance 2250, taurultam analogue
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Geistlich Pharma AG, Panavance Therap
Drug class:
Reactive oxygen species stimulant, NF-κB inhibitor, GAPDH inhibitor
Related drugs:
‹
verteporfin (10)
STA-4783 (5)
AU-011 (1)
BOLD-100 (0)
temoporfin (0)
porfimer sodium (0)
lyso-thermosensitive liposomal doxorubicin (0)
darinaparsin (0)
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
CBL137 IV (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
verteporfin (10)
STA-4783 (5)
AU-011 (1)
BOLD-100 (0)
temoporfin (0)
porfimer sodium (0)
lyso-thermosensitive liposomal doxorubicin (0)
darinaparsin (0)
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
CBL137 IV (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login